Good morning :)
$
₹
D

DAVION+HEALTHCARE+PLC

DAVI

US
D

DAVION+HEALTHCARE+PLC

DAVI

US
$4.0732.08% (-1.92)
$
₹
$4.0732.08% (-1.92)
High
—
—
Low
—
—
Returns
—
—
Loading...
1D
1W
1M
3M
6M
1Y
3Y
5Y
Max

Healthcare

Medical Instruments & Supplies

Micro Cap

-

Key Metrics

Key Metrics

PE TTM
PE TTM

Close price divided by the earnings per share for the trailing twelve months

—
PB
PB

Close price divided by the book value per share at the end of the most recent quarter

0
EPS TTM
EPS TTM

Net profit earned per share over the trailing twelve months (sum of the last 4 quarters)

$-0.05
PEG Ratio
PEG Ratio

Price-to-Earnings (P/E) ratio divided by the forecasted annual earnings per share (EPS) growth rate over the next five years

—
Profit Margin
Profit Margin

Net profit divided by the total revenue for the most recent financial year

0%
Dividend Yield
Dividend Yield

Annual dividend per share for the trailing twelve months divided by the close price

—

Company Profile

Company Profile

Davion Healthcare Plc, a digital healthcare company, engages in the design, development, and commercialization of non-invasive health monitoring technologies. Its core consumer health portfolio comprises proprietary, home-based monitoring devices designed to support the early identification of potential medical anomalies. The company's flagship product, BreastCheck, is an FDA-registered at-home breast health screening test designed to identify potential abnormalities through changes in breast temperature. It is also developing a portfolio of proprietary health monitoring technologies, including FootFlow for monitoring indicators associated with circulation and diabetes-related blood flow issues; Testic, an at-home testicular health monitoring system; and ThermaDerm for the identification of skin anomalies, as well as technologies addressing wound monitoring, blood pressure, and other areas of preventive healthcare. The company was incorporated in 2022 and is based in Cork, Ireland.
Davion Healthcare Plc, a digital healthcare company, engages in the design, development, and commercialization of non-invasive health monitoring technologies. Its core consumer health portfolio comprises proprietary, home-based monitoring devices designed to support the early identification of potential medical anomalies. The company's flagship product, BreastCheck, is an FDA-registered at-home breast health screening test designed to identify potential abnormalities through changes in breast temperature. It is also developing a portfolio of proprietary health monitoring technologies, including FootFlow for monitoring indicators associated with circulation and diabetes-related blood flow issues; Testic, an at-home testicular health monitoring system; and ThermaDerm for the identification of skin anomalies, as well as technologies addressing wound monitoring, blood pressure, and other areas of preventive healthcare. The company was incorporated in 2022 and is based in Cork, Ireland.

Forecast

Forecast

empty forecast

Forecast data is currently unavailable

Forecast data is currently unavailable

Price

Price Upside

Revenue

Revenue Growth

Earnings

Earnings Per Share

Financials

Financials

Income

Balance Sheet

Cash Flow

Q2 2025
Q4 2025
Revenue
Net Income
Financial YearQ2 2025Q4 2025
Total Revenue--
Net Income--
Net Profit Margin--
See CostsAll values in $ Billion

Peers

Price Comparison

Compare DAVI with any stocks or ETF

Hmm, looks like data is currently unavailable. Once it's updated, you can view it here

Frequently asked questions

  1. DAVION+HEALTHCARE+PLC (DAVI) share price today is $4.07 as of October 27, 2026 at 12:05 AM IST. The stock touched a day high of $4.82 and a day low of $3.96.

  2. DAVION+HEALTHCARE+PLC stock trades on US under the ticker symbol DAVI.

  3. DAVION+HEALTHCARE+PLC's market capitalization is $150M as of October 27, 2026 at 12:05 AM IST.

  4. DAVION+HEALTHCARE+PLC's price-to-earnings (P/E) ratio is N/A as of October 26, 2026.

  5. DAVION+HEALTHCARE+PLC's price-to-book (P/B) ratio is 0 as of October 26, 2026.

  6. Yes, You can buy DAVION+HEALTHCARE+PLC shares from India through Tickertape, via our partnership with ViewTrade IFSC under the IFSCA Global Access framework, subject to RBI’s Liberalised Remittance Scheme (LRS) limits.

  7. Indian investors can buy DAVION+HEALTHCARE+PLC shares in three steps: 1. Search DAVION+HEALTHCARE+PLC on the Tickertape app and tap Invest. 2. Complete your one-time digital KYC. 3. Fund your account and buy from as low as $1 via fractional shares.

  8. Since DAVION+HEALTHCARE+PLC trades in USD, an Indian investor's INR returns depend on both the stock's price movement and the USD-INR exchange rate. If the rupee depreciates against the dollar, INR returns are boosted beyond the stock's USD return; if the rupee appreciates, INR returns are reduced.

  9. Indian investors can start investing in DAVION+HEALTHCARE+PLC (DAVI) shares from as little as $1 through fractional ownership on Tickertape - for example, $10 buys approximately 2.4539 shares at the current price of $4.07.

Loading...